Skip to main content

Advertisement

Table 2 All-cause mortality and cardio-cerebrovascular events mortality (/1000 persons/year)

From: Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes

Patients Group All-cause death Mortality (95%CI) Cardio-cerebrovascular events death Mortality (95%CI)
Total Diabetes 18 4.5 (3.67–5.98) 5 1.3 (0.98–1.65)
Diabetes combined with hyperlipidemia 32 8.4 (6.09–9.24)a 14 3.7 (2.97–4.02)a
< 65 years Diabetes 9 2.2 (1.87–2.48) 3 0.6 (0.38–0.78)
Diabetes combined with hyperlipidemia 21 5.4 (4.81–5.94)a 8 1.7 (1.42–2.02)a
≥ 65 years Diabetes 26 5.2 (4.89–5.42) 5 0.9 (0.88–1.02)
Diabetes combined with hyperlipidemia 23 5.4 (5.11–5.64) 6 1.1 (0.97–1.12)
Female Diabetes 5 1.1 (0.87–1.28) 2 0.4 (0.28–0.53)
Diabetes combined with hyperlipidemia 17 4.4 (4.22–4.74)a 7 1.5 (1.42–1.62)a
Male Diabetes 11 3.1 (2.87–3.28) 4 0.7 (0.64–0.83)
Diabetes combined with hyperlipidemia 25 4.9 (4.82–5.14)a 9 1.9 (1.83–2.02)a
Family history Diabetes 10 2.8 (2.57–2.98) 6 0.6 (0.58–0.73)
  Diabetes combined with hyperlipidemia 25 5.9 (5.53–6.14)a 12 1.9 (1.83–2.02)a
No family history Diabetes 17 3.6 (3.37–3.88) 10 1.6 (1.48–1.73)
  Diabetes combined with hyperlipidemia 20 3.9 (3.53–4.14) 12 1.9 (1.83–2.02)
  1. CI confidence interval
  2. Note: aP < 0.05, which is compared with the same patients in diabetes group